Skip to content

Discontinued — last reported Q3 '22

D&A at other companies

Henry Schein logo
Henry ScheinHSIC
$81M+11.0%
Globus Medical logo
Globus MedicalGMED
$29.53M-55.3%
Novanta logo
NovantaNOVT
$5.77M+4.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$30.5M+4.1%
RadNet logo
RadNetRDNT
$44.97M+26.7%
Solventum logo
SolventumSOLV

Segments

By segment

See full
Specialty Products & Technologies$22.4M+8.7%
Equipment & Consumables$6.2M-10.1%

Other financials

Income statement

See full
Revenue$705.5M+14.4%
Gross profit$390.1M+16.1%
Operating income$62.5M+60.3%
Net income$38.7M+115%
EPS (diluted)$0.23+130%

Balance sheet

See full
Cash & equivalents$1.1B+0.5%
Total debt$1.6B+1.8%
Total equity$3.1B+1.4%
Total assets$5.6B+2.0%

Cash flow

See full
Operating cash flow-$3.3M-1,200%
CapEx$12.5M+112%
Free cash flow-$15.8M-182%

Valuation

See full
Market cap$4.11B+39.9%

Profitability

See full
Gross margin54.9%+0.9pp
Operating margin8.5%+4.6pp
Net margin2.4%+1.2pp
FCF margin7.8%-2.9pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.5×0.0×
Current ratio2.4×+0.3×

Where this comes from

Reported directly by Envista Holdings Corporation in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Envista Holdings Corporation’s 10-Q, filed November 3, 2022, on SEC EDGAR. View the filing →

Ask your AI about Envista Holdings Corporation's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envista Holdings Corporation's D&A?
Envista Holdings Corporation (NVST) reported D&A of $7.8M in Q3 2022.
How has Envista Holdings Corporation's D&A changed year-over-year?
Envista Holdings Corporation's D&A decreased by 17.9% year-over-year, from $9.5M to $7.8M.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.